Study Group for Japan's Future through Regenerative Medicine Holds Joint Symposium with the Japanese Society for Regenerative Medicine, Sharing Discussions for the Next 10 Years.
The Graduate School of Project Design co-hosted a symposium with JSrm to discuss the roadmap for the social implementation and industrialization of regenerative medicine by 2030 and 2040.
📋 Article Processing Timeline
- 📰 Published: March 31, 2026 at 00:00
- 🔍 Collected: March 30, 2026 at 22:56
- 🤖 AI Analyzed: April 24, 2026 at 08:14 (585h 18m after Collected)
The 'Study Group for Japan's Future through Regenerative Medicine,' an industry-academia-government collaboration initiative led by the Graduate School of Project Design, Advanced Institute of Industrial Technology (Headquarters: Minato-ku, Tokyo; President: Risa Tanaka), held a co-hosted symposium with the Japanese Society for Regenerative Medicine (JSrm) on March 20, 2026, at the 25th Congress of the JSrm (Kobe City; Congress President: Masayo Takahashi).
## The Future of Regenerative Medicine and the Path to Social Implementation Envisioned through Government-Industry-Academia Collaboration
Cutting-edge medical fields, including regenerative medicine, are highly expected to contribute significantly to strengthening Japan's international competitiveness and extending the healthy life expectancy of its citizens. On the other hand, because it is a new medical field, verifying its safety and efficacy requires a long time and a massive amount of money, and various challenges regarding the regulatory system have also been pointed out.
Under these circumstances, what kind of efforts are required to implement regenerative medicine into society and develop it as one of Japan's primary industries? Launched in 2023 as a place to deepen discussions on what regenerative medicine should ideally look like, the 'Study Group for Japan's Future through Regenerative Medicine' brings together experts from government, industry, and academia involved in regenerative medicine to continuously discuss the challenges and ideal visions for its healthy development.
In formulating a roadmap for the future, the group aims to realize 'social implementation of regenerative medicine,' 'industrialization,' 'system development,' and 'promotion of understanding' by 2030. Looking further ahead to 2040, it envisions a future where regenerative medicine is established as a common treatment and Japan becomes a global leader driving the regenerative medicine field in both economic and industrial aspects.
## Joint Symposium by the Study Group and JSrm
The 'Study Group for Japan's Future through Regenerative Medicine' set 'The Next 10 Years of Regenerative Medicine' as its theme for fiscal year 2025, deepening discussions from three perspectives: 'Acceleration of Innovation,' 'Clinical Evaluation of Regenerative Medicine/Cell Therapy Products,' and 'Medical Insurance Finance and Public Understanding.' At the co-hosted symposium, a panel discussion was held based on these points, and important perspectives and directions for the further development of regenerative medicine were shared.
## The Future of Regenerative Medicine and the Path to Social Implementation Envisioned through Government-Industry-Academia Collaboration
Cutting-edge medical fields, including regenerative medicine, are highly expected to contribute significantly to strengthening Japan's international competitiveness and extending the healthy life expectancy of its citizens. On the other hand, because it is a new medical field, verifying its safety and efficacy requires a long time and a massive amount of money, and various challenges regarding the regulatory system have also been pointed out.
Under these circumstances, what kind of efforts are required to implement regenerative medicine into society and develop it as one of Japan's primary industries? Launched in 2023 as a place to deepen discussions on what regenerative medicine should ideally look like, the 'Study Group for Japan's Future through Regenerative Medicine' brings together experts from government, industry, and academia involved in regenerative medicine to continuously discuss the challenges and ideal visions for its healthy development.
In formulating a roadmap for the future, the group aims to realize 'social implementation of regenerative medicine,' 'industrialization,' 'system development,' and 'promotion of understanding' by 2030. Looking further ahead to 2040, it envisions a future where regenerative medicine is established as a common treatment and Japan becomes a global leader driving the regenerative medicine field in both economic and industrial aspects.
## Joint Symposium by the Study Group and JSrm
The 'Study Group for Japan's Future through Regenerative Medicine' set 'The Next 10 Years of Regenerative Medicine' as its theme for fiscal year 2025, deepening discussions from three perspectives: 'Acceleration of Innovation,' 'Clinical Evaluation of Regenerative Medicine/Cell Therapy Products,' and 'Medical Insurance Finance and Public Understanding.' At the co-hosted symposium, a panel discussion was held based on these points, and important perspectives and directions for the further development of regenerative medicine were shared.